Field-deployable hydrogel platform using surface-enhanced Raman scattering (SERS) for direct detection of GMO genetic material in plants. The technology combines metallic nanostar sensors with functional nucleic acids in a hydrogel matrix, enabling multiplexed, reagentless detection with a handheld Raman reader and minimal sample processing.
This technology adapts SERS-sensing hydrogels—originally developed for in situ detection of plant viral infections—to the direct detection of genetically modified organisms (GMOs) in the field. The platform addresses the need for rapid, on-site genetic testing without the laboratory infrastructure required by PCR-based methods. By modifying the post-contact processing of the hydrogel, the team aims to free genomic DNA from plant tissue and detect GMO-specific sequences directly on the leaf surface.
The approach offers a practical solution for agricultural stakeholders, regulatory bodies, and seed producers who need fast, portable confirmation of GMO status. Its field-ready design, multiplexed readout, and minimal sample preparation make it well suited for deployment in greenhouses, field testing stations, and supply chain verification.
Core technology components:
Detection workflow:
Validation status to date:
The SERS-sensing hydrogel platform has been validated for viral detection in plants through controlled greenhouse experiments. The current TRL reflects demonstrated proof-of-concept for the core sensing mechanism and hydrogel-based extraction, with viral load quantification confirmed by orthogonal methods.
The proposed work focuses on extending the platform to GMO detection, which requires optimizing post-contact processing to free genomic DNA and validating sensor compatibility with plant genetic material. Planned activities include evaluating temperature and buffer conditions for DNA release, testing multiplexing with multiple GMO-specific sensors, and introducing remedial strategies if sensor incompatibility arises. The technology is positioned at an early-to-mid stage of development for GMO applications, with a clear pathway toward field validation and multiplexed assay deployment.
The University of Cincinnati is a comprehensive public research university with an applied, urban-serving character and a significant clinical enterprise. Industry engages through one of the nation's largest cooperative education programs, placing students year-round with corporate R&D and operations teams and creating an on-ramp to sponsored research. An innovation district near campus hosts co-located corporate labs, startup space, and shared prototyping facilities, while the university's integration with a major hospital system enables clinical studies and translation. Research is supported by competitive federal funding from agencies such as NIH and NSF, along with state and industry partnerships. A dedicated technology transfer office manages IP, licensing, corporate agreements, and startup formation, providing flexible models for collaboration.